Evidence map›Paper›PMID 37047683›Full record

ArticleInternational journal of molecular sciences2023

Distinctive Kaposi Sarcoma-Associated Herpesvirus Serological Profile during Acute

Peter O Oluoch, Catherine S Forconi, Cliff I Oduor, Dominic A Ritacco, Hoseah M Akala, Jeffrey A Bailey, Jonathan J Juliano, John M Ong'echa, Christian Münz, Ann M Moormann

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Peter O OluochDivision of Infectious Diseases and Immunology, Department of Medicine, Chan Medical School, University of Massachusetts, Worcester, MA 01605, USA.ORCID 0000-0001-7451-4993
Catherine S ForconiDivision of Infectious Diseases and Immunology, Department of Medicine, Chan Medical School, University of Massachusetts, Worcester, MA 01605, USA.ORCID 0000-0001-7358-5546
Cliff I OduorCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.
Dominic A RitaccoDivision of Infectious Diseases and Immunology, Department of Medicine, Chan Medical School, University of Massachusetts, Worcester, MA 01605, USA.
Hoseah M AkalaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.ORCID 0000-0001-8584-2706
Jeffrey A BaileyDepartment of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Jonathan J JulianoDivision of Infectious Diseases, Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
John M Ong'echaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu 40100, Kenya.ORCID 0000-0003-3928-6774
Christian MünzViral Immunobiology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland.ORCID 0000-0001-6419-1940
Ann M MoormannDivision of Infectious Diseases and Immunology, Department of Medicine, Chan Medical School, University of Massachusetts, Worcester, MA 01605, USA.ORCID 0000-0003-1113-2829
University of Massachusetts Chan Medical School · USBrown University · USKenya Medical Research Institute · KEUniversity of North Carolina at Chapel Hill · USUniversity of Zurich · CH

Funding

Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphomaR01CA189806 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORMANN, ANN M · 2014 to 2024
$5.7M
Mentoring in Translational Malaria GenomicsK24AI134990 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Jonathan J Juliano · 2018 to 2026
$1.6M
NCI NIH HHS R01 CA189806NIAID NIH HHS K24 AI134990NIH HHS R01AI121588; K24AI134990; R01CA189806
6 · The paper itself

Abstract

The seroprevalence of Kaposi sarcoma-associated herpesvirus (KSHV) and the incidence of endemic Kaposi sarcoma (KS) overlap with regions of malaria endemicity in sub-Saharan Africa. Multiple studies have shown an increased risk of KSHV seroconversion in children from high malaria compared to low malaria regions; however, the impact of acute episodes of

Indexed as

Epstein-Barr Virus InfectionsHerpesvirus 8, HumanMalaria, FalciparumSarcoma, KaposiChildHerpesvirus 4, HumanHumansMalariaSeroepidemiologic Studiesacute malaria infectionendemic Kaposi sarcomaEpstein–Barr virusKaposi sarcoma-associated herpesvirusKenyalytic replicationsub-Saharan Africa

Identifiers

PMID37047683
PMCPMC10095526
OpenAlexW4362559545

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.